A significant deal has been announced in the radiopharmaceutical industry. Curium, a company in this field, has agreed to acquire Lantheus Holdings. The deal is valued at up to $8 billion.

Further details about the acquisition are available from the source. The agreement is part of Curium's efforts to expand its presence in the industry. The Galveston County Daily News is a source for more information on this development, although specific local implications are not immediately clear from the available details.